G0S2 and thyroid cancer: Kim et al. have demonstrated that the G0S2 gene is significantly upregulated in BRAF V600E cells compared to wild-type BRAF human thyroid cells, and this expression change caused by the BRAF V600E mutation may have an important role in thyroid cancer development [42].